Kaduk, James A.’s team published research in Powder Diffraction in 36 | CAS: 375815-87-5

Powder Diffraction published new progress about 375815-87-5. 375815-87-5 belongs to quinoxaline, auxiliary class Neuronal Signaling,AChR,Natural product, name is 7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate, and the molecular formula is C17H19N3O6, COA of Formula: C17H19N3O6.

Kaduk, James A. published the artcilePowder X-ray diffraction of varenicline hydrogen tartrate Form B (Chantix), (C13H14N3)(HC4H4O6), COA of Formula: C17H19N3O6, the publication is Powder Diffraction (2021), 36(3), 202-204, database is CAplus.

The crystal structure of varenicline hydrogen tartrate Form B (Chantix) has been refined using synchrotron X-ray powder diffraction data and optimized using d. functional techniques. Varenicline hydrogen tartrate Form B crystallizes in space group P212121 (#19) with a = 7.07616(2), b = 7.78357(2), c = 29.86149(7) Å, V = 1644.706(6) Å3, and Z = 4. The hydrogen bonds were identified and quantified. Hydrogen bonds link the cations and anions in zig-zag chains along the b-axis. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (PDF).

Powder Diffraction published new progress about 375815-87-5. 375815-87-5 belongs to quinoxaline, auxiliary class Neuronal Signaling,AChR,Natural product, name is 7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate, and the molecular formula is C17H19N3O6, COA of Formula: C17H19N3O6.

Referemce:
https://en.wikipedia.org/wiki/Quinoxaline,
Quinoxaline | C8H6N2 | ChemSpider